Quantitative and qualitative QuantiFERON®-TB Gold In-Tube results among groups with varying risks of exposure to tuberculosis

Heart and Lung: Journal of Acute and Critical Care

Volumn 41, Issue 6, 2012, Pages 553-561

  Simpson, Terri ^a   Fox, Joyce ^b   Crouse, Karen ^b   Field, Kimberly ^c  

^a UNIVERSITY OF WASHINGTON   (United States)

^b Spokane Regional Health District   (United States)

^c WASHINGTON STATE DEPARTMENT OF HEALTH   (United States)

Author keywords

Interferon release assays; Latent tuberculosis infection; QuantiFERON TB Gold In Tube; Tuberculosis prevention and control; Tuberculosis screening

Indexed keywords

GAMMA INTERFERON; QUANTIFERON; UNCLASSIFIED DRUG;

AFRICAN AMERICAN; AMERICAN INDIAN; ARTICLE; CAUCASIAN; CONTROLLED STUDY; CYTOKINE PRODUCTION; EMPLOYMENT; ENVIRONMENTAL EXPOSURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HIGH RISK POPULATION; HUMAN; IMMUNE FUNCTION TEST; IMMUNOASSAY; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PACIFIC ISLANDER; PRACTICE GUIDELINE; PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUANTIFERON TB GOLD IN TUBE; QUANTITATIVE ANALYSIS; RACE DIFFERENCE; RETROSPECTIVE STUDY; RISK ASSESSMENT; SCREENING TEST; TUBERCULIN TEST; TUBERCULOSIS;

ADULT; ANTIGENS, BACTERIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; INTERFERON-GAMMA; MALE; MYCOBACTERIUM TUBERCULOSIS; NORTHWESTERN UNITED STATES; RECOMBINANT PROTEINS; REPRODUCIBILITY OF RESULTS; RETROSPECTIVE STUDIES; TUBERCULOSIS;

EID: 84868302559     PISSN: 01479563     EISSN: 15273288     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2012.06.005     Document Type: Article

References (19)

1. Centers for Disease Control and Prevention Latent tuberculosis infection: a guide for primary health care providers 2010, Centers for Disease Control and Prevention, Atlanta, GA, Available at:. http://www.cdc.gov/tb/publications/LTBI/pdf/TargetedLTBI.pdf.
2. American Thoracic Society, Centers for Disease Control and Prevention, Infectious Diseases Society of America. Controlling tuberculosis in the United States. Am J Respir Crit Care Med 2005, 172:1169-1227.
3. Mazurek G.H., Jereb J., Vernon A., LoBue P., Goldberg S., Castro K., et al. Updated guidelines for using interferon gamma release assays to detect Mycobacterium tuberculosis infection-United States, 2010. MMWR Recomm Rep 2010, 59:1-25. IGRA Expert Committee, Centers for Disease Control and PreventionCenters for Disease Control and Prevention.
4. Ringshausen F.C., Nienhaus A., Torres Costa J., Knoop H., Schlösser S., Schultze-Werninghaus G., et al. Within-subject variability of Mycobacterium tuberculosis-specific gamma interferon responses to German health care workers. Clin Vaccine Immunol 2011, 18:1176.
5. Torres Costa J., Silva R., Sá R., Cardoso M.J., Nienhaus A. Serial testing with interferon-γ release assay in Portuguese healthcare workers. Int Arch Occup Environ Health 2011, 84:461-469.
6. Schablon A., Harling M., Diel R., Ringshausen F.C., Torres Costa J., Nienhaus A. Serial testing with an interferon-γ release assay in German healthcare workers. GMS Krankenhhyg Interdiszip 2010, 5:1-8.
7. Diel R., Loddenkemper R., Nienhaus A. Evidence-based comparison of commercial interferon-γ release assays for detecting active TB: a metaanalysis. Chest 2010, 137:952-968.
8. ®-TB Gold In-Tube in human immunodeficiency virus infection and in patient candidates for anti-tumour necrosis factor-alpha treatment. Int J Tuberc Lung Dis 2010, 14:834-840.
9. Simpson T., Fox J., Crouse K., Field K. Screening for Mycobacterium tuberculosis using an interferon-gamma release assay. J Public Health Manag Pract 2011, 18:E19-E25.
10. Pai M., Dheda K., Cunningham J., Scano F., O'Brien R. T-cell assays for the diagnosis of latent tuberculosis infection: moving the research agenda forward. Lancet Infect Dis 2007, 7:428-438.
11. Pai M., Joshi R., Dogra S., Zwerling A.A., Gajalakshmi D., Goswami K., et al. T-cell assay conversions and reversions among household contacts of tuberculosis patients in rural India. Int J Tuberc Lung Dis 2009, 13:84-92.
12. Baker C.A., Thomas W., Stauffer W.M., Peterson P.K., Tsukayama D.T. Serial testing of refugees for latent tuberculosis using the QuantiFERON-Gold In-Tube: effects of an antecedent tuberculin skin test. Am J Trop Med Hyg 2009, 80:628-633.
13. Cellestis. QuantiFERON®-TB Gold results interpretation guide (2007). Valencia, CA: Cellestis; 2007. Available at: http://www.cellestis.com/IRM/Company/ShowPage.aspx%3fCPID%3d1215.
14. Powell R.D., Whitworth W.C., Bernardo J., Moonan P.K., Mazurek G.H. Unusual interferon gamma measurements with QuantiFERON-TB Gold and QuantiFERON-TB Gold In-Tube tests. PLoS ONE 2011, 6:e20061.
15. van Zyl-Smit R.N., Pai M., Peprah K., Meldau R., Kieck J., Juritz J., et al. Within-subject variability and boosting of T-cell interferon-γ responses after tuberculin skin testing. Am J Respir Crit Care Med 2009, 180:49-58.
16. Lange B., Vavra M., Kern W.V., Wagner D. Indeterminate results of a tuberculosis-specific interferon-γ release assay in immunocompromised patients. Eur Respir J 2010, 35:1179-1182.
17. Richeldi L., Losi M., D'Amico R., Luppi M., Ferrari A., Mussini C., et al. Performance of tests for latent tuberculosis in different groups of immunocompromised patients. Chest 2009, 136:198-204.
18. Talati N.J., Seybold U., Humphrey B., Aina A., Tapia J., Weinfurter P., et al. Poor concordance between interferon-γ release assays and tuberculin skin tests in diagnosis of latent tuberculosis infection among HIV-infected individuals. BMC Infect Dis 2009, 9:15.
19. Bocchino M., Matarese A., Bellofiore B., Giacomelli P., Santoro G., Balato N., et al. Performance of two commercial blood IFN-γ release assays for the detection of Mycobacterium tuberculosis infection in patient candidates for anti-TNF-α treatment. Eur J Clin Microbiol Infect Dis 2008, 27:907-913.